Invention Grant
US08501473B2 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
失效
pleitrophin用于预防和治疗胰腺疾病和/或肥胖症和/或代谢综合征的用途
- Patent Title: Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
- Patent Title (中): pleitrophin用于预防和治疗胰腺疾病和/或肥胖症和/或代谢综合征的用途
-
Application No.: US10564769Application Date: 2004-07-15
-
Publication No.: US08501473B2Publication Date: 2013-08-06
- Inventor: Daria Onichtchouk , Ulrike Burk
- Applicant: Daria Onichtchouk , Ulrike Burk
- Applicant Address: DE Hamburg
- Assignee: Evotec International GmbH
- Current Assignee: Evotec International GmbH
- Current Assignee Address: DE Hamburg
- Agency: Millen, White, Zelano, Branigan, P.C.
- Priority: EP03016169 20030716
- International Application: PCT/EP2004/007917 WO 20040715
- International Announcement: WO2005/014022 WO 20050217
- Main IPC: C12N5/06
- IPC: C12N5/06 ; C12N5/08
Abstract:
The present invention discloses the protein pleiotrophin secreted by the developing pancreas, and polynucleotides, which identify and encode this protein. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.
Public/Granted literature
Information query
